Results 201 to 210 of about 137,095 (246)

Burden of Invasive Fungal Diseases in Patients With Alcohol‐Related Hepatitis and Organ Failure

Alimentary Pharmacology &Therapeutics, EarlyView.
Between 2012 and 2021 in France, invasive fungal diseases affected 1 in 50 patients with alcohol‐related hepatitis and at least two hepatic or extrahepatic complications, with substantially higher mortality than bacterial pneumonia. These findings support targeted screening and early antifungal strategies in this population, as currently recommended ...
Charlotte Mouliade, Lucia Parlati, Stylianos Tzedakis, Mathis Collier, Samir Bouam, Philippe Sogni, Fanny Lanternier, Alexandre Alanio, Vincent Mallet, Demosthenes Research Group   +9 more
wiley   +1 more source

Feasibility and efficacy of pH-integrated ultrathin endoscopy for ambulatory gastroesophageal reflux monitoring (with videos). [PDF]

Gastroenterol Rep (Oxf)
Hu X, Zhang Y, Hao J, Tang B, Zhang Y, Huang X.   +5 more
europepmc   +1 more source

Comparative Risk of Hepatitis B Virus Reactivation in Patients Receiving Immune Checkpoint Inhibitors or Tyrosine Kinase Inhibitors for Liver Cancer

Alimentary Pharmacology &Therapeutics, EarlyView.
In a cohort of 1596 liver cancer patients with either current or prior HBV infection undergoing systemic therapy in Hong Kong, the risk of HBV reactivation during immune checkpoint inhibitor treatment was low when adequate antiviral prophylaxis was administered, irrespective of HBV infection status.
Dorothy Cheuk‐Yan Yiu, Jimmy Che‐To Lai, Landon Long Chan, Grace Lai‐Hung Wong, Mandy Sze‐Man Lai, Vincent Wai‐Sun Wong, Yee‐Kit Tse, Henry Lik‐Yuen Chan, Stephen Lam Chan, Terry Cheuk‐Fung Yip   +9 more
wiley   +1 more source

MYC Phosphorylation as a Cellular Switch in Primary Sclerosing Cholangitis: A Breakthrough in Understanding Cholangiocyte Fate. [PDF]

Cell Mol Gastroenterol Hepatol
Rodriguez A, Glaser SS.
europepmc   +1 more source

Non‐Response to Obeticholic Acid Is Associated With Heightened Risks of Developing Clinical Events in Primary Biliary Cholangitis

Alimentary Pharmacology &Therapeutics, EarlyView.
In a multi‐centre study of obeticholic acid in primary biliary cholangitis, 45% discontinued the drug over 4 years, with 11% moving to combination therapy (fibrates). Of those continuing, response rates increased from 37% (1 year) to 55% (4 years). Non‐response at 12 months and cirrhosis were independent predictors of liver‐related events.
Nadir Abbas, Rachel Smith, Ellina Lytvyak, Miki Scaravaglio, Neil Halliday, Amal Almahroos, Nadia Eden, Diane Lloyd‐Madden, Sanchit Sharma, James Ferguson, Jessica K. Dyson, Douglas Thorburn, David Jones, Aldo J. Montano‐Loza, Marco Carbone, Pietro Invernizzi, George Mells, Emma L. Culver, Palak J. Trivedi   +18 more
wiley   +1 more source

Alterations in Gut Microbiota and Metabolism in Cirrhotic Portal Hypertension: Implications for Disease Progression

Alimentary Pharmacology &Therapeutics, EarlyView.
In‐depth multiomics analyses revealed that the gut microbiota in patients with CPH is dysbiotic. Altered gut microbiota plays an important role in the progression of CPH and affects the host's arginine metabolism to promote arginine biosynthesis. The pro‐inflammatory effects of certain gut bacteria induce iNOS expression, which together act on the ...
Qun Zhang, Jinghua Cui, Yixin Hou, Lining Guo, Hai Li, Guiqin Zhou, Xiaojing Wang, Bingbing Zhu, Ke Shi, Yi Zhang, Yufei Bi, Yanqiu Li, Lina Sun, Ying Feng, Jing Yuan, Xianbo Wang   +15 more
wiley   +1 more source

Minimum standards for training in colorectal endoscopic mucosal resection among advanced endoscopy trainees

Endoscopy International Open
Dennis Yang, Ernesto Robalino Gonzaga, Muhammad Khalid Hasan, Arvind Julius Trindade, Mark Radlinski, Rebecca A Burbridge, Jeffrey Mosko, Pushpak Taunk, Salmaan Jawaid, Mohamed O. Othman, David L Diehl, Harshit S. Khara, Quin Liu, Srinivas Gaddam, Harry Aslanian, Shailendra S Chauhan, Amrita Sethi, John Poneros, Jason Samarasena, Ali M Ahmed, Uzma D. Siddiqui, Dennis Chen, Moamen Gabr, Andrew Y. Wang, C-EMR STAT Working Group   +24 more
doaj   +1 more source

The role of oral microbiota in digestive system diseases: current advances and perspectives. [PDF]

J Oral Microbiol
Li Y, Xin Y, Zong W, Li X.
europepmc   +1 more source

Prevalence of Opioid Use and Associated Healthcare Outcomes in Rome IV Irritable Bowel Syndrome in the United Kingdom

Alimentary Pharmacology &Therapeutics, EarlyView.
One in five people with Rome IV irritable bowel syndrome use opioids on a regular basis. Compared with non‐users, opioid users had worse quality of life, greater psychological impairment, and higher direct healthcare costs. ABSTRACT Background The United Kingdom (UK) has one of the highest worldwide opioid prescription rates per capita.
Mohsin F. Butt, Vivek C. Goodoory, Cho Ee Ng, Christopher J. Black, Alexander C. Ford, Maura Corsetti, Peter Paine   +6 more
wiley   +1 more source

The Bethesda ERCP Skills Assessment Tool (BESAT) can reliably differentiate endoscopists of different experience levels

Endoscopy International Open
Kevin Liu, B. Joseph Elmunzer, Sachin Wani, Tiffany Taft, Catharine M Walsh, Mustafa A Arain, Tyler M. Berzin, James Buxbaum, Christopher DiMaio, Syed M. Abbas Fehmi, Neil Gupta, Sreenivasa Jonnalagadda, Vladimir Kushnir, John T. Maple, Raman Muthusamy, Amit Rastogi, Janak N Shah, Amitabh Chak, Ashley Faulx, Nauzer Forbes, Rajesh N Keswani   +20 more
doaj   +1 more source